Todd Zavodnick
Chief Executive Officer presso Dermavant Sciences Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Mark Foley | M | 58 | 12 anni | |
| Kenneth Ludlum | M | 70 |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018.
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | 5 anni |
| Timothy Nelson | M | 60 |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018.
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | 5 anni |
| Ambrose Bailey | M | 60 | 7 anni | |
| Tobin Schilke | M | 49 | 6 anni | |
| Myrtle Potter | F | 65 |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom.
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 6 anni |
| Yen You Zheng | M | 67 | 5 anni | |
| Frank Torti | M | 45 |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom.
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 6 anni |
| Sigurd Kirk | M | 57 | 7 anni | |
| Nancy Beesley | F | - |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 2 anni |
| Conor Gallagher | M | - | 6 anni | |
| Kira Schwartz | F | - | 7 anni | |
| James Joseph Florio | M | 86 |
Rutgers State University of New Jersey
| 30 anni |
| Michael B. Clement | M | 67 |
The University of Texas at Austin
| 20 anni |
| Frederick C. Beddingfield | M | 59 |
Children's Skin Disease Foundation
| - |
| Merrick McCracken | M | - |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | 14 anni |
| Igor Correia de Almeida | M | 63 |
The University of Texas at Austin
| 20 anni |
| John Donofrio | M | 56 |
Children's Skin Disease Foundation
| - |
| Chris Chapman | M | - |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | 4 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Mark M. Sieczkarek | M | 69 | 5 anni | |
| John J. McGovern | M | - | 2 anni | |
| Cyril Allouche | M | 52 | 2 anni | |
| Dustin Sjuts | M | 45 | 6 anni | |
| Richard A. Leavy | M | - |
Rutgers State University of New Jersey
| 9 anni |
| Joel Marc Kallman | M | - |
Rutgers State University of New Jersey
| - |
| Danika R. Harrison | F | 48 | 3 anni | |
| Brendan Achariyakosol | M | - |
The University of Texas at Austin
| 11 anni |
| Matthew D. Boyd | M | - |
The University of Texas at Austin
| 5 anni |
| Joel A. Shapiro | M | 53 |
Rutgers State University of New Jersey
| 7 anni |
| Phillip C. Zerrillo | M | 65 |
The University of Texas at Austin
| 5 anni |
| Hemant Pande | M | - |
Rutgers State University of New Jersey
| 5 anni |
| John Batton | M | - |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | 3 anni |
| Kyle Hranicky | M | - |
The University of Texas at Austin
| 5 anni |
| Mohammed Hoque | M | 46 |
The University of Texas at Austin
| 5 anni |
| Stuart Raetzman | M | 61 |
Galderma Laboratories LP
 Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX.
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | - |
| Christy Cardenas | F | 37 |
The University of Texas at Austin
| 5 anni |
| Andrew Schiff | M | 58 | 7 anni | |
| Prem Nainani | M | - |
The University of Texas at Austin
| 6 anni |
| Eric Pearson | M | - |
The University of Texas at Austin
| 5 anni |
| Jim Ciprich | M | - |
Rutgers State University of New Jersey
| 6 anni |
| Natasha Tosirisuk | F | - |
The University of Texas at Austin
| 5 anni |
| Kendall Helfenbein | M | - |
The University of Texas at Austin
| 4 anni |
| Chien Chung Nieh | M | 64 |
Rutgers State University of New Jersey
| 4 anni |
| Justin Bernard Smith | M | - |
The University of Texas at Austin
| 5 anni |
| Caryn G. McDowell | F | 54 | - | |
| Rui Mao | M | 49 |
The University of Texas at Austin
| 3 anni |
| Marvin Kwan | M | - |
The University of Texas at Austin
| 5 anni |
| Turab Bajwa | M | - |
The University of Texas at Austin
| 5 anni |
| Sam F. Stoutner | M | 37 |
The University of Texas at Austin
| 5 anni |
| Steven Hirsch | M | - |
The University of Texas at Austin
| 5 anni |
| Rachel Foley | F | - |
The University of Texas at Austin
| 4 anni |
| Daniel G. Polhamus | M | - |
The University of Texas at Austin
| 5 anni |
| SHORT REBECCA | F | - |
The University of Texas at Austin
| 4 anni |
| B. M. Rankin | M | 94 |
The University of Texas at Austin
| 7 anni |
| D. Grossman | M | 63 | 4 anni | |
| Kevin O'Boyle | M | 68 | 6 anni | |
| John Moran | M | 48 |
Rutgers State University of New Jersey
| 6 anni |
| Keith Sullivan | M | 65 | 5 anni | |
| Mary Fisher | F | 62 | 5 anni | |
| Lauren Silvernail | F | 65 | 5 anni | |
| T. Alex McPherson | M | 85 | 10 anni | |
| Sergio Garcia-Rodriguez | M | 62 | 5 anni | |
| John Blair Cummings | M | - |
Rutgers State University of New Jersey
| 11 anni |
| Alex Greyserman | M | - |
Rutgers State University of New Jersey
| 5 anni |
| Leonard Goldberg | M | 61 |
Rutgers State University of New Jersey
| 13 anni |
| Zhaobo Wang | M | 67 |
Rutgers State University of New Jersey
| 4 anni |
| David Endicott | M | 58 | 1 anni | |
| Michael Ian Mellon | M | - |
The University of Texas at Austin
| 5 anni |
| Ali Merchant | M | - |
The University of Texas at Austin
| 5 anni |
| Bryan Roberts | M | 57 | 8 anni | |
| Wesley Gallup | M | - |
The University of Texas at Austin
| 6 anni |
| Shari Ledbetter | F | - |
The University of Texas at Austin
| 5 anni |
| Vincent Ippolito | M | 65 |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 2 anni |
| Megan Light | F | - |
The University of Texas at Austin
| 5 anni |
| Massimo Radaelli | M | 65 | 2 anni | |
| Patrick Williams | M | 51 | 4 anni | |
| Ashley Baum | F | - |
The University of Texas at Austin
| 5 anni |
| Michael Schemick | M | 50 |
Rutgers State University of New Jersey
| 6 anni |
| Ronald Eastman | M | 71 | 8 anni | |
| Michael Parent | M | - |
The University of Texas at Austin
| 4 anni |
| David Sobernheim | M | - |
The University of Texas at Austin
| 3 anni |
| Ryan Deschner | M | - |
The University of Texas at Austin
| 4 anni |
| Francisco Campos | M | - |
The University of Texas at Austin
| 1 anni |
| Naveen Jayasundaram | M | - |
The University of Texas at Austin
| 4 anni |
| Kevin J. L’abbé | M | 43 |
The University of Texas at Austin
| 4 anni |
| Nicholas van Loan | M | - |
The University of Texas at Austin
| 3 anni |
| Matthew Hartman | M | - |
The University of Texas at Austin
| 2 anni |
| Ankit Dalal | M | - |
The University of Texas at Austin
| 4 anni |
| Xi Chen | M | - |
The University of Texas at Austin
| 5 anni |
| John Johanning | M | 38 |
The University of Texas at Austin
| 4 anni |
| Chris Robertson | M | - |
The University of Texas at Austin
| 4 anni |
| Joanne Choi | F | - |
The University of Texas at Austin
| 4 anni |
| Jeoffrey Restituto Lambujon | M | - |
The University of Texas at Austin
| 5 anni |
| Alexander Farquharson | M | 40 |
The University of Texas at Austin
| 4 anni |
| Tyler Dunn | M | - |
The University of Texas at Austin
| 4 anni |
| Scotty Reynolds | M | - |
The University of Texas at Austin
| 4 anni |
| Amrita Dukeshier | F | - |
The University of Texas at Austin
| 2 anni |
| Russell Chad Mollen | M | 41 |
The University of Texas at Austin
| 4 anni |
| Jordan Waldrep | M | - |
The University of Texas at Austin
| 2 anni |
| Said Aziz | M | - |
The University of Texas at Austin
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 86 | 86.00% |
| Francia | 13 | 13.00% |
| Regno Unito | 5 | 5.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Todd Zavodnick
- Contatti personali
